Abstract:Mosaic chromosomal alterations (mCAs) have been implicated in neuropsychiatric disorders, but their contribution to schizophrenia (SCZ) during early developmental stages remains unclear. This study aimed to explore the relationship between mCAs and schizophrenia in a Chinese population. A genome-wide analysis of mCAs was performed on 9,715 SCZ patients and 28,822 controls of Chinese descent. Blood-derived DNA genotyping intensity data were used for mCA detection utilizing phase-based computational techniques. The overall burden of mCAs was assessed based on size and type. Differences in gene frequencies affected by identified mCAs were also evaluated. Statistical significance was determined using permutation procedures by label-swapping individual phenotypes (10E6 ×). Additionally, genome-wide genotyping data of postmortem brain tissues from 936 individuals (449 SCZ cases and 487 controls) were collected for validation. SCZ patients exhibited a significantly higher mCA detection rate compared to control subjects (3.12% vs. 1.91%, P < × 10E-6). Partitioned analyses by mCA size indicated the heaviest burden for short mCAs (≤4 Mb, 1.35% vs. 0.61%, P < 1 × 10E-6). Specific mCAs associated with SCZ were identified, including the well-known 22q11.21 deletion SCZ genetic risk factor and several novel loci (e.g., 12q21.31-21.32 losses). Deletions at 22q11.21 and 12q21.31-21.32 were further validated as recurrent and over-represented in brain genomes of SCZ patients (odds ratio>3). This study demonstrated that mCAs contribute significantly to the risk of SCZ by genotyping blood-derived DNA. A greater mCA burden was observed in SCZ individuals compared to controls. Furthermore, specific mCAs conferring SCZ risk were identified, with two of them being supported by brain tissue analysis. These findings suggest that mCAs play a crucial role in and enhance our understanding of the genetic structure of SCZ.

Somatic mosaicism in schizophrenia brains reveals prenatal mutational processes

Exploration of cell type–specific somatic mutations in schizophrenia and the impact of maternal immune activation on the somatic mutation profile in the brain

The Contribution of Mosaic Chromosomal Alterations to Schizophrenia

Mtdna Heteroplasmy in Monozygotic Twins Discordant for Schizophrenia

Somatic mosaicism and neurodevelopmental disease

Somatic mosaicism reveals clonal distributions of neocortical development

Intersection of diverse neuronal genomes and neuropsychiatric disease: The Brain Somatic Mosaicism Network

Somatic Mutations in Cerebral Cortical Malformations.

Comprehensive identification of somatic nucleotide variants in human brain tissue

Somatic Mosaicism and Autism Spectrum Disorder

Longitudinal Transcriptomic Analysis of Human Cortical Spheroids Identifies Axonal Dysregulation in the Prenatal Brain as a Mediator of Genetic Risk for Schizophrenia

W96. INVESTIGATING THE RELATIONSHIP BETWEEN MOSAIC CHROMOSOMAL ALTERATIONS AND SCHIZOPHRENIA

Failure to Identify Somatic Mutations in Monozygotic Twins Discordant for Schizophrenia by Whole Exome Sequencing.

The landscape of somatic mutation in cerebral cortex of autistic and neurotypical individuals revealed by ultra-deep whole-genome sequencing

Whole-genome Sequencing of Monozygotic Twins Discordant for Schizophrenia Indicates Multiple Genetic Risk Factors for Schizophrenia.

Somatic mosaicism detected by genome-wide sequencing in 500 parent-child trios with suspected genetic disease: clinical and genetic counseling implications

Genetic Diversity in Schizophrenia: Developmental Implications of Ultra-Rare, Protein-Truncating Mutations

Somatic mosaicism in the diseased brain

Genetic mosaicism in the human brain: from lineage tracing to neuropsychiatric disorders

Identification of De Novo Mutations in Prenatal Neurodevelopment-Associated Genes in Schizophrenia in Two Han Chinese Patient-Sibling Family-Based Cohorts

Genomic data resources of the Brain Somatic Mosaicism Network for neuropsychiatric diseases